<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04814537</url>
  </required_header>
  <id_info>
    <org_study_id>2020P003241</org_study_id>
    <nct_id>NCT04814537</nct_id>
  </id_info>
  <brief_title>Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques</brief_title>
  <official_title>A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of&#xD;
      patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of our study is to use a biased coin up-down allocation methodology to&#xD;
      estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of&#xD;
      patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor induction&#xD;
      or augmentation; we hypothesize that we will be able to determine the ED90 of bupivacaine for&#xD;
      each technique with adequate precision to inform the optimal doses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 25, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Controlled Trial Using Biased Coin Design to Determine Effective Dose for 90% (ED90) of Subjects</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>The biased-coin allocation after each successful response will be implemented by flipping a virtual biased coin (10% vs. 90% probability of randomizing the next patient to the lower vs. same dose than received by the last patient with the same epidural technique) using R statistical software (R Foundation for Statistical Computing, Vienna, Austria). Care Provider (Clinical Anesthesiologist) will administer the identified dose, then summon blinded observer.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Rating Score &lt; 3/10</measure>
    <time_frame>30 min</time_frame>
    <description>Pain Score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Labor Pain</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Dural Puncture Epidural Technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laboring women receiving the Dural Puncture Epidural (DPE) Technique with dose of Bupivacaine 0.25% diluted to 20 mL with isotonic sterile 0.9% saline. The first subject in the DPE group will receive an initial dose of bupivacaine 25 mg, with an endpoint being the achievement of an NRS &lt; 3 at 30 min. Subsequent patients are administered bupivacaine doses determined by the response of the previous subject, as per the biased coin method. The subsequent up and down interval doses are bupivacaine 2.5 mg (1 mL) increments, with an anticipated dose range from 20 mg to 40 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laboring women receiving the Conventional Epidural Technique (EPL) with dose of Bupivacaine 0.25% diluted to 20 mL with isotonic sterile 0.9% saline. The first subject in the EPL group will receive an initial dose of bupivacaine 25 mg, with an endpoint being the achievement of an NRS &lt; 3 at 30 min. Subsequent patients are administered bupivacaine doses determined by the response of the previous subject, as per the biased coin method. The subsequent up and down interval doses are bupivacaine 2.5 mg (1 mL) increments, with an anticipated dose range from 20 mg to 40 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride</intervention_name>
    <description>Local Anesthetic Agent</description>
    <arm_group_label>Dural Puncture Epidural Technique</arm_group_label>
    <arm_group_label>Epidural Technique</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Parturient with no major co-morbidities&#xD;
&#xD;
          2. Singleton, vertex gestation at term (38-42 weeks)&#xD;
&#xD;
          3. Less than 5 cm dilation&#xD;
&#xD;
          4. Desire to receive epidural labor analgesia&#xD;
&#xD;
          5. Numerical Rating Scale &gt; 5 (NRS 0-10, where 0 = no pain, and 10 = worst pain&#xD;
             imaginable), at time of epidural labor analgesia request.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Current or historical evidence of clinically significant disease or condition,&#xD;
             including diseases of pregnancy (i.e preeclampsia, gestational diabetes)&#xD;
&#xD;
          2. Any contraindication to the administration of an epidural technique&#xD;
&#xD;
          3. History of hypersensitivity or idiosyncratic reaction to an amide local anesthetic&#xD;
             agent&#xD;
&#xD;
          4. Current or historical evidence of a disease which may result in the risk of a cesarean&#xD;
             delivery (i.e. vaginal birth after cesarean delivery, history of uterine rupture)&#xD;
&#xD;
          5. Evidence of anticipated fetal anomalies&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant Women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence Tsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor in Anesthesiology, Harvard Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lawrence Tsen, MD</last_name>
    <phone>617-732-8216</phone>
    <email>ltsen@bwh.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lawrence C Tsen, MD</last_name>
      <phone>617-732-8216</phone>
      <email>ltsen@zeus.bwh.harvard.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Ngan Kee WD, Ng FF, Khaw KS, Lee A, Gin T. Determination and comparison of graded dose-response curves for epidural bupivacaine and ropivacaine for analgesia in laboring nulliparous women. Anesthesiology. 2010 Aug;113(2):445-53. doi: 10.1097/ALN.0b013e3181bdf9da.</citation>
    <PMID>20613484</PMID>
  </results_reference>
  <results_reference>
    <citation>Benhamou D, Ghosh C, Mercier FJ. A randomized sequential allocation study to determine the minimum effective analgesic concentration of levobupivacaine and ropivacaine in patients receiving epidural analgesia for labor. Anesthesiology. 2003 Dec;99(6):1383-6.</citation>
    <PMID>14639153</PMID>
  </results_reference>
  <results_reference>
    <citation>Chau A, Bibbo C, Huang CC, Elterman KG, Cappiello EC, Robinson JN, Tsen LC. Dural Puncture Epidural Technique Improves Labor Analgesia Quality With Fewer Side Effects Compared With Epidural and Combined Spinal Epidural Techniques: A Randomized Clinical Trial. Anesth Analg. 2017 Feb;124(2):560-569. doi: 10.1213/ANE.0000000000001798.</citation>
    <PMID>28067707</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Lawrence Ching Tsen</investigator_full_name>
    <investigator_title>Associate Professor of Anesthesia</investigator_title>
  </responsible_party>
  <keyword>Dural Puncture Epidural Technique</keyword>
  <keyword>Epidural Technique</keyword>
  <keyword>Neuraxial Labor Analgesia</keyword>
  <keyword>Bupivacaine</keyword>
  <keyword>Local Anesthetic Agent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

